Chiba Soutaro, Kondo Hideki, Miyanishi Masaki, Andika Ida Bagus, Han Chenggui, Tamada Tetsuo
Institute of Plant Science and Bioresources, Okayama University, Kurashiki, Okayama, 710-0046, Japan.
Mol Plant Microbe Interact. 2011 Feb;24(2):207-18. doi: 10.1094/MPMI-10-10-0241.
Beet necrotic yellow vein virus (BNYVV) is an economically important pathogen of sugar beet and has been found worldwide, probably as the result of recent worldwide spread. The BNYVV genome consists of four or five RNA components. Here, we report analysis of sequence variation in the RNA3-p25, RNA4-p31, RNA2-CP, and RNA5-p26 genes of 73 worldwide isolates. The RNA3-p25 gene encodes virulence and avirulence factors. These four sets of gene sequences each fell into two to four groups, of which the three groups of p25 formed eight subgroups with different geographical distributions. Each of these subgroup isolates (strains) could have arisen from four original BNYVV population and their mixed infections. The genetic diversity for BNYVV was relatively small. Selection pressure varied greatly depending on the BNYVV gene and geographical location. Isolates of the Italy strain, in which p25 was subject to the strongest positive selection, were able to overcome the Rz1-host resistance gene to differing degrees, whereas other geographically limited strains could not. Resistance-breaking variants were generated by p25 amino acid changes at positions 67 and 68. Our studies suggest that BNYVV originally evolved in East Asia and has recently become a pathogen of cultivated sugar beet followed by the emergence of new resistance-breaking variants.
甜菜坏死黄脉病毒(BNYVV)是一种对甜菜具有重要经济影响的病原体,已在全球范围内被发现,这可能是近期全球传播的结果。BNYVV基因组由四个或五个RNA组分组成。在此,我们报告了对73个全球分离株的RNA3-p25、RNA4-p31、RNA2-CP和RNA5-p26基因序列变异的分析。RNA3-p25基因编码毒力和无毒力因子。这四组基因序列各自分为两到四个组,其中p25的三组形成了具有不同地理分布的八个亚组。这些亚组分离株(菌株)中的每一个可能都源自四个原始的BNYVV群体及其混合感染。BNYVV的遗传多样性相对较小。选择压力因BNYVV基因和地理位置的不同而有很大差异。意大利菌株的分离株中,p25受到最强的正选择,能够不同程度地克服Rz1宿主抗性基因,而其他地理范围有限的菌株则不能。p25基因第67和68位氨基酸的变化产生了抗性突破变异体。我们的研究表明,BNYVV最初在东亚进化,最近成为栽培甜菜的病原体,随后出现了新的抗性突破变异体。